{"ticker": {"uuid": "31eb5de8-5e84-4e38-ba2e-0b160353627c", "symbol": "ABVX", "name": "ABIVAX Soci\u00e9t\u00e9 Anonyme", "exchange": "PAR", "country": "FR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Brummer Multi Strategy AB Boosts Position in Abivax SA Sponsored ADR $ABVX", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQeTdUZ3AweGI5VkM3bDhZcEd0RVNVbTRmX3U3SndLLUdEUVF1cFNGUWttVXdpTUR4cXNoSEYybk82Q1laNlJCVFVTVXNSa1hONDVJZUlQRkg3SDIxQmhfbnZOdVBrMV9ycWJqVEFBUVFSaTNmekMwOXpNWGdPYVFEbzhDS2E2U0szMUFBNGdnNkQyNktfLXVuUTVXSE1wbHFhcHEwRkVfUTU3NUtnNDVPT1hSdUZTX2JzVGZ2S3djZUFTR2R5TGlvQ2hhODd4MXM?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-17T08:56:00+00:00", "published_display": "17 Jul 2026 08:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Obefazimod Goes The Distance And So Does My Buy Rating (NASDAQ:ABVX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxON0xEZmNGUEgwUWhzYWxYdUE3WlhWbEhOb0duYUNyV09aOFZZT1hyMENZMDIzYzJvNWp0TUs0ODZGNUJfRkY1QWVsN2JXM2htNUxUcWRtcmVSN3JnOTM4NGtaV1REak5talM3cGV0eU10MzN2MURKeU5xMUpfQTBiYWdWSDY0UGM0ZXg3Z1hYRUFGOWc5SXlXY1plb2lXZTY5V3ZoWg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T14:25:31+00:00", "published_display": "16 Jul 2026 14:25", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Diversify Wealth Management LLC Purchases 14,626 Shares of Abivax SA Sponsored ADR $ABVX", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOTkpyRmlud3B1eU00MFV4ODF4OW1WZWJvT3ZDNnAwN0R6d0QxQVE1cXdaUzJ6QnpYNG1zaGRqM2lfdGZWQm1ualJRR2pHLVF4WlozSDFTOU9LVWlnc0tKSUdiUjMzWnY0RldmLUt2MW5nUUdjWHVyck5sQ0lvX0hlRDdNWEhwWGVQTTF0TVJmWGRzZVNWandhWnFvdnlQbnF3UjhHU2s3eERRUWlqVWFxT1F0eVFyWk5FTnRLdUN0bTYzQjVNRjdMeHBwNUgwVnhOZ052TWFUYlFEdjdldnJDdQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T07:52:32+00:00", "published_display": "15 Jul 2026 07:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Candriam S.C.A. Takes $4.01 Million Position in Abivax SA Sponsored ADR $ABVX", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOSm5aMS14bUFxSEcxcHJoNmhMVlBZcHFkSkhmVktqa09RQU5BOEhQNUVrbWhqeHV4UzRQNF9aYldpZE1LeEdYNlc0YnctU0d1T0xGTEM4cTdTSFdXZ0U1N3Njc2VYdXhSYTVBNzB0X2c0T3hHR0k3bFczVHZTVk52TnRpYldZbXZGSFFJcDU4aUhLbVEwNk1LbDlWNFhFZGZXRjViRTB5MGdaaG4yZ2lTY3ktTDNXTEZtX1BlVE5HckJ5UUJMaUcwSVo1eGQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-14T07:50:43+00:00", "published_display": "14 Jul 2026 07:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Abivax Sa (ABVX) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQTngtT1U2dGtDeDF1S3BGTE9Oa3B1MlQ4bGwxaFgzR3JWdDkwZkszRXVWZndvRTJoR1UyQ0xPZjc4cmNad29rNU92RlMtcVNBTVM4TFB6ZDl5NUJEUExoMl9hVDdNQmcxSjZHWFR0MGZIdWUxUExTM1Rxd3JDSGNNOWItNjFDLTdTX1FTeWxYbDNwb0VaQzVWNkVCcWpfeEttZHZWOEsyUzMzOG5jZ1FfejNLTWhCNFQ0M0YtaWhrcHZDUExaYnRB?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-12T08:46:02+00:00", "published_display": "12 Jul 2026 08:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Wall Street Catches Up to the Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNSi04MnMwS3hOVFNoUWhieWRvWmhNUFlwZnNCTm5sZDJRaUJrc1NMM2s1RllCUzN1a3Qzckc1NGpVN1NaWWFqSnpRakJrS3FOYm1NWGxHdHZiR19DRFp3U0Vjd0d4RnpHZml2WFVjbGVNWUZNaF92cTl5azNlUG9KR2luYXNabkFUY3pUTTI1VFM3Q3RXbnBZ?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ABIVAX Soci\u00e9t\u00e9 Anonyme (ABVX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNY2FmMkpYbDMyZnhPRVVuODMzNEFXNTdtNGtUeDd4MHJaOHZBWHh4cDZiUDRpSmZ1cm9Oa0VjcXdKLUJSbVNFMzRRc290Zk5ybWZlU05JOVVNcm55akZpdDhERFdUWjFUMDZfNnhDaHBPamd5ZlZlVFBKOEQ2RjhuX29SSXA1T3lGYk9SU2RhOEtYSm5jdGc?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet \u2013 Buyout Chatter Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQkRXQy1LMXZFVUlQNUJ6VmFVUEZKcmFLUHNjWFhFM0VLVFZ0UjhuNE5Xd2JTc1B0Z2hIa1lXTGRtV09FV0pGMXcwTUNoeDRSajdiSmxKQjBacVBzWEFFblVUVUpqNWwwY055M2RmRk9LQ1lkSzNSU0lIblQ2ZmVCWnhYMWx1WlBNSHUxQWQ1M3U1bXM?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax raises $800M as dilution hits 8% and cash reaches 2029", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNzA2RWlWV2VJcFB2eFI2WmtwNm1BMFVFZGhIN2dvaGhndmRNdDdaQmdaRzRyaTVWNEpNRnE3cXgtNktQSXlHekppN0pNbWM1MW41SWpWbXZtRHFNNHFBZzFyWmhLenptSXoyUGg3WXVLZXYyb29HNFduSWFlZlZPMmZTaThKdFJ2dGc1Q1AyM0sybUVHSTA3STNlNHJpTGpHV2pwZmZWS2tndWJBTHdNRTNjWjF3QnFSSkxZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNOGxRTUp4NGFHV1kxb25FUGtUejkzREdtb2lGRjE3aHNiOEVCVmRQZmhnd2xuUEw4YW9FaHRBUVV3emJhcnRwZDFPVURwRkF0R3ZIeExhX3RZT09BNU1LdV9kSGZrekpyS0pQb2ZQa00wbm9UME5qV2V2emRscjBGQzM2aW1sa0VtQkhGcWQ4R09DSjFVcHc?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks making the biggest moves midday: AeroVironment, Abivax, Astera Labs, Watts Water Technologies & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSlQ3OXF6bXJwSmdBZHlObEpYWE9ZcFdHblJnLVJYOHNVYjdpMTFrZzFsZ3UxbWhoYnpTY3hfT1hWWlBLUXg4ak5aakpBNUQwTDltNl9POERaVXNmaExheVZfVGc4dmJyOHRoZzRqcnNiSUxhRnF1S29sUm9UeXdsbGZxOEYzWEUydEhZcHB0TWVKY0ZVRC1rQ1Rn?oc=5", "source_name": "CNBC", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPc0FxVTNVaGFuVl81UDM1Rk9OdjNqQjFaOWN6cEV5T2tiNFU2Zm9aZk0yZGFjUGxoTF9YSDRnOUVudlhzeXBfVmdwazFzWG80Y1hpTkRyWE9zeDlRSDdvbGdCaHlSVGdsRktZTnBwVXJJZlJRUEgyX2NYSUNIenJ2TGh6NnVZejFGLUltazhlNTFRNzd4dENSX3drd3ZVSTZRQmJ6Y3pQWTNoa1NjamdocWdNcmx3MWlNYU9hZ2VPYUNlc3pIcEJyRk1pQndkeGZnUnB0bjRtbnB3QWpuQ3hhdg?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-29T23:57:14+00:00", "published_display": "29 Jun 2026 23:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Safety Signals Loom Ahead Of The NDA Submission", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPbDgtQ3ZoV2Voc3cxakItbElNMDN6a0t6aTc1em12enU4bkktMU5vNVZjUVFGM3hiaDNxNzNJc1VNQVd2VmdMSkpMRVlwenpmc1pZX2dhanNVVUs0c0hSLURYS3VZdjhQbWZOM3RzU1NqOHV1NjdxV3ZHazJlclc4aHExdHpQTU1HQ1RQeEtISEdhSGhDUVFTTGRBNA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax (ABVX) Jumps 16% on Bargain-Hunting", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOUTdTalFmbGFneHFEUGVNTU9NeHQ4NjQ1aHdTa2JRdlphcWFWSl9zcUJvUDd0Y1FZMHMtemdhckFWaF80UzVmWUpwSFRqcDNaSzFjWmdGeFI2N2pIcU9wb3AxQlRNVDg1a09DOEpTa0p2bEh3S0FsMVppMHVLdlV4aXhmQ0hIM3BkUTItbDQyWTlKb0tzMDcySA?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax Shares Tumble Despite Strong Ulcerative Colitis Trial Results as Safety Concerns Emerge (ABVX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOd0pweWNiQlBUQ3paNzMwZzhvZk1ZR0JpUmJMMVBnY3FSS2twa1B6dUM1alJnbzVIaFRlX1lvZDlpZWZSb0ZxallPcThvNkZZUkx2YnVFaGVDUXlENXh6VlJSZk1MZkJweHZGcTlFeTFSd3FMTXV0V0hsdC1fak80OTZ5U2NyZzlSb1RRNTNYVTAzMGJVMmpMSFNhYm1RendHdHM1RXVmRQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQYXVfVjVSdXNiYmluVFFXbGZMaVZuMVp1RE9xQ0NfXzA5QUljd25GVjI0Tzh4VERiXzZpVUxDN3ZPa21MYUlVc0xKVkxMX212QnFLa3haRXZkTFIxR05pb01CN0FhRmVtdGQtRnVERkdZUmY5MmhXRHF3X0laR1o0ZDdJcUtGYnprdVlkaFJkcUx0bWdLcDlIblVn?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing ABIVAX Soci\u00e9t\u00e9 Anonyme (ENXTPA:ABVX) Valuation After Recent Share Price Softness And Conflicting Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPcF9UUjJDZHVTaHo3ZHRaaUFnWkVrdlk3RmhCVmVFTDZ3d3l1a2FIdjgzYTlTUzh4MjA3aWMtWWM2cTJsY28xTlF3em1NSHZ4Z3liNWZYVktWdGUyMVlLQ3lPd3JiVHVBaVRMYlAxNjJRR3c0YnpmOXIzdEZFM282U3ktRWI3T2RZc0Vwam5GWTAwVjB3RGs3VFp5blM?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX (ABVX) Appoints Michael Nesrallah as Chief Commercial Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPaE5ybTFpYkl2V3hUTkJGRmh6Q0xqaTZPbzN3TTFlT3hjd3hudWF0TGI2aEdCemtnSjNndVduRFAyNmdhN2ZLWnNXeG02NkVBRDlraElPbDU5VlVLZENOYno2NnFOUEprVWVxdEl3SzB2WE1tam5BOVhNM2Z0YlRSdm9GVXZKVXBHODFCVGJxVWVzOVR1TVJjeUhHN2RPd3dTU3B0Q2lR?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2 Reasons Abivax Stock Could 10X by 2036", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQc0g4S0Rqdk5DSExGdWd6NXplbjQyM2wwZWhRaHd4MVVKTEw1SmNfR1R6NGNRWURncW9GYVNwdjl4Uk1EV2xEVkE5d3pYWW9hYUpTbENPelFRQV9uYTdIVmpXaGNyTW9VaHFXUld0LUZKeDR4ZzdqTl9OWVZlT0xCUlZNeGx6OFpLSjJCMTlUZlFOdUljUDRwMHNPOVNKN1ZReTZFczZwV2loQjNHVHU4ZkgtRDBpbXNMSHc?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX Societe Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOZFN1M3ZlRlhrcENZTUJUdzRGc1g0ZHlFSVBvRERrOVNFT1JDeGV3NG93bEJBT3RkRTB4UjZoUlJCSXE3MFZEbHJKdERaemtwYThSNHp6b0FwazlyWV85OHFtS2JiNWtHVnQxWV9zZ29mZ1MtN3dWMGU5dUhPZElVek1iQTNkb09hZHF4eWx6ekFBM3lRV0c1ZmdHaGJwVWppYjd2MmpNVVRjUml5LU55UWZ1cXk2VUc2cEVFaGVia1BnV1NMTE9Yb0N1WFRZcFh3RFN1cXczZmI?oc=5", "source_name": "Finviz", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX Soci\u00e9t\u00e9 Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE0teHlFaEFzYmRPY01yTzJ1Um9DeVJjOTFnMktrejZiWGZkS3FfZ2EySW44QW01TjAxOEx6X0Ria3ZYNElXWW14Wm5vNW1pOFYyV3VkUk5vYmJDUUlKSGZsSHZkdnVhM1c3OWk1ZllQNHEzaXJYOV96aEIzWGg?oc=5", "source_name": "Market source", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Abivax Stock Was on Fire Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQd1g2SVRJOVA0Ny1mSWNNQVZjcEpxNHo5NTRXaTdnZGRkN2ZnSWtBcXE2Ym9QeXhxWVgydDhQeEZ2a1p5eXk0UUVYWW1kLTR2SUQ3MVhtV280enJQNFZtS290ZEpWSU1RS0Q1VXJuVktQbW9uWFhYX1Z3NU5Nb1JST0s3Zw?oc=5", "source_name": "The Motley Fool", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOVTdyUW5zT0llemlMZEQ1WFJDN2hQZHZlVWl0NlYyUnYzcWtvZW41WlZkcTNTLTRQSnF6bEhxSmd5M2ZROXZqNnMyVkJJNkV5WFhfSWdhUkpQRlhwYldxbUdqclJFSU9RRnhubFM1STBkLVZLLU84T2l5UGFrdUpBN0lHejlQR1EyNWotel81NXd6amUwZWkxMWFkZEw3UVp4MTlVNTBJUGVhalZwV1I3ZHNn?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-07-19T07:00:00+00:00", "published_display": "19 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Brummer Multi Strategy AB Boosts Position in Abivax SA Sponsored ADR $ABVX", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQeTdUZ3AweGI5VkM3bDhZcEd0RVNVbTRmX3U3SndLLUdEUVF1cFNGUWttVXdpTUR4cXNoSEYybk82Q1laNlJCVFVTVXNSa1hONDVJZUlQRkg3SDIxQmhfbnZOdVBrMV9ycWJqVEFBUVFSaTNmekMwOXpNWGdPYVFEbzhDS2E2U0szMUFBNGdnNkQyNktfLXVuUTVXSE1wbHFhcHEwRkVfUTU3NUtnNDVPT1hSdUZTX2JzVGZ2S3djZUFTR2R5TGlvQ2hhODd4MXM?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-17T08:56:00+00:00", "published_display": "17 Jul 2026 08:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Obefazimod Goes The Distance And So Does My Buy Rating (NASDAQ:ABVX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxON0xEZmNGUEgwUWhzYWxYdUE3WlhWbEhOb0duYUNyV09aOFZZT1hyMENZMDIzYzJvNWp0TUs0ODZGNUJfRkY1QWVsN2JXM2htNUxUcWRtcmVSN3JnOTM4NGtaV1REak5talM3cGV0eU10MzN2MURKeU5xMUpfQTBiYWdWSDY0UGM0ZXg3Z1hYRUFGOWc5SXlXY1plb2lXZTY5V3ZoWg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T14:25:31+00:00", "published_display": "16 Jul 2026 14:25", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Diversify Wealth Management LLC Purchases 14,626 Shares of Abivax SA Sponsored ADR $ABVX", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOTkpyRmlud3B1eU00MFV4ODF4OW1WZWJvT3ZDNnAwN0R6d0QxQVE1cXdaUzJ6QnpYNG1zaGRqM2lfdGZWQm1ualJRR2pHLVF4WlozSDFTOU9LVWlnc0tKSUdiUjMzWnY0RldmLUt2MW5nUUdjWHVyck5sQ0lvX0hlRDdNWEhwWGVQTTF0TVJmWGRzZVNWandhWnFvdnlQbnF3UjhHU2s3eERRUWlqVWFxT1F0eVFyWk5FTnRLdUN0bTYzQjVNRjdMeHBwNUgwVnhOZ052TWFUYlFEdjdldnJDdQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-15T07:52:32+00:00", "published_display": "15 Jul 2026 07:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Candriam S.C.A. Takes $4.01 Million Position in Abivax SA Sponsored ADR $ABVX", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOSm5aMS14bUFxSEcxcHJoNmhMVlBZcHFkSkhmVktqa09RQU5BOEhQNUVrbWhqeHV4UzRQNF9aYldpZE1LeEdYNlc0YnctU0d1T0xGTEM4cTdTSFdXZ0U1N3Njc2VYdXhSYTVBNzB0X2c0T3hHR0k3bFczVHZTVk52TnRpYldZbXZGSFFJcDU4aUhLbVEwNk1LbDlWNFhFZGZXRjViRTB5MGdaaG4yZ2lTY3ktTDNXTEZtX1BlVE5HckJ5UUJMaUcwSVo1eGQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-14T07:50:43+00:00", "published_display": "14 Jul 2026 07:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Precision Trading with Abivax Sa (ABVX) Risk Zones", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQTngtT1U2dGtDeDF1S3BGTE9Oa3B1MlQ4bGwxaFgzR3JWdDkwZkszRXVWZndvRTJoR1UyQ0xPZjc4cmNad29rNU92RlMtcVNBTVM4TFB6ZDl5NUJEUExoMl9hVDdNQmcxSjZHWFR0MGZIdWUxUExTM1Rxd3JDSGNNOWItNjFDLTdTX1FTeWxYbDNwb0VaQzVWNkVCcWpfeEttZHZWOEsyUzMzOG5jZ1FfejNLTWhCNFQ0M0YtaWhrcHZDUExaYnRB?oc=5", "source_name": "Stock Traders Daily", "published_at": "2026-07-12T08:46:02+00:00", "published_display": "12 Jul 2026 08:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Wall Street Catches Up to the Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNSi04MnMwS3hOVFNoUWhieWRvWmhNUFlwZnNCTm5sZDJRaUJrc1NMM2s1RllCUzN1a3Qzckc1NGpVN1NaWWFqSnpRakJrS3FOYm1NWGxHdHZiR19DRFp3U0Vjd0d4RnpHZml2WFVjbGVNWUZNaF92cTl5azNlUG9KR2luYXNabkFUY3pUTTI1VFM3Q3RXbnBZ?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ABIVAX Soci\u00e9t\u00e9 Anonyme (ABVX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNY2FmMkpYbDMyZnhPRVVuODMzNEFXNTdtNGtUeDd4MHJaOHZBWHh4cDZiUDRpSmZ1cm9Oa0VjcXdKLUJSbVNFMzRRc290Zk5ybWZlU05JOVVNcm55akZpdDhERFdUWjFUMDZfNnhDaHBPamd5ZlZlVFBKOEQ2RjhuX29SSXA1T3lGYk9SU2RhOEtYSm5jdGc?oc=5", "source_name": "Market source", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABVX Stock Eyes Over Six-Month High As Investors Double Down On Abivax's Lead Drug Bet \u2013 Buyout Chatter Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQQkRXQy1LMXZFVUlQNUJ6VmFVUEZKcmFLUHNjWFhFM0VLVFZ0UjhuNE5Xd2JTc1B0Z2hIa1lXTGRtV09FV0pGMXcwTUNoeDRSajdiSmxKQjBacVBzWEFFblVUVUpqNWwwY055M2RmRk9LQ1lkSzNSU0lIblQ2ZmVCWnhYMWx1WlBNSHUxQWQ1M3U1bXM?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax raises $800M as dilution hits 8% and cash reaches 2029", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNzA2RWlWV2VJcFB2eFI2WmtwNm1BMFVFZGhIN2dvaGhndmRNdDdaQmdaRzRyaTVWNEpNRnE3cXgtNktQSXlHekppN0pNbWM1MW41SWpWbXZtRHFNNHFBZzFyWmhLenptSXoyUGg3WXVLZXYyb29HNFduSWFlZlZPMmZTaThKdFJ2dGc1Q1AyM0sybUVHSTA3STNlNHJpTGpHV2pwZmZWS2tndWJBTHdNRTNjWjF3QnFSSkxZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX (ENXTPA:ABVX) Stock Looks Expensive Even After Strong Trial Progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNOGxRTUp4NGFHV1kxb25FUGtUejkzREdtb2lGRjE3aHNiOEVCVmRQZmhnd2xuUEw4YW9FaHRBUVV3emJhcnRwZDFPVURwRkF0R3ZIeExhX3RZT09BNU1LdV9kSGZrekpyS0pQb2ZQa00wbm9UME5qV2V2emRscjBGQzM2aW1sa0VtQkhGcWQ4R09DSjFVcHc?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks making the biggest moves midday: AeroVironment, Abivax, Astera Labs, Watts Water Technologies & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSlQ3OXF6bXJwSmdBZHlObEpYWE9ZcFdHblJnLVJYOHNVYjdpMTFrZzFsZ3UxbWhoYnpTY3hfT1hWWlBLUXg4ak5aakpBNUQwTDltNl9POERaVXNmaExheVZfVGc4dmJyOHRoZzRqcnNiSUxhRnF1S29sUm9UeXdsbGZxOEYzWEUydEhZcHB0TWVKY0ZVRC1rQ1Rn?oc=5", "source_name": "CNBC", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPc0FxVTNVaGFuVl81UDM1Rk9OdjNqQjFaOWN6cEV5T2tiNFU2Zm9aZk0yZGFjUGxoTF9YSDRnOUVudlhzeXBfVmdwazFzWG80Y1hpTkRyWE9zeDlRSDdvbGdCaHlSVGdsRktZTnBwVXJJZlJRUEgyX2NYSUNIenJ2TGh6NnVZejFGLUltazhlNTFRNzd4dENSX3drd3ZVSTZRQmJ6Y3pQWTNoa1NjamdocWdNcmx3MWlNYU9hZ2VPYUNlc3pIcEJyRk1pQndkeGZnUnB0bjRtbnB3QWpuQ3hhdg?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-29T23:57:14+00:00", "published_display": "29 Jun 2026 23:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Safety Signals Loom Ahead Of The NDA Submission", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPbDgtQ3ZoV2Voc3cxakItbElNMDN6a0t6aTc1em12enU4bkktMU5vNVZjUVFGM3hiaDNxNzNJc1VNQVd2VmdMSkpMRVlwenpmc1pZX2dhanNVVUs0c0hSLURYS3VZdjhQbWZOM3RzU1NqOHV1NjdxV3ZHazJlclc4aHExdHpQTU1HQ1RQeEtISEdhSGhDUVFTTGRBNA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax (ABVX) Jumps 16% on Bargain-Hunting", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOUTdTalFmbGFneHFEUGVNTU9NeHQ4NjQ1aHdTa2JRdlphcWFWSl9zcUJvUDd0Y1FZMHMtemdhckFWaF80UzVmWUpwSFRqcDNaSzFjWmdGeFI2N2pIcU9wb3AxQlRNVDg1a09DOEpTa0p2bEh3S0FsMVppMHVLdlV4aXhmQ0hIM3BkUTItbDQyWTlKb0tzMDcySA?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax Shares Tumble Despite Strong Ulcerative Colitis Trial Results as Safety Concerns Emerge (ABVX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOd0pweWNiQlBUQ3paNzMwZzhvZk1ZR0JpUmJMMVBnY3FSS2twa1B6dUM1alJnbzVIaFRlX1lvZDlpZWZSb0ZxallPcThvNkZZUkx2YnVFaGVDUXlENXh6VlJSZk1MZkJweHZGcTlFeTFSd3FMTXV0V0hsdC1fak80OTZ5U2NyZzlSb1RRNTNYVTAzMGJVMmpMSFNhYm1RendHdHM1RXVmRQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQYXVfVjVSdXNiYmluVFFXbGZMaVZuMVp1RE9xQ0NfXzA5QUljd25GVjI0Tzh4VERiXzZpVUxDN3ZPa21MYUlVc0xKVkxMX212QnFLa3haRXZkTFIxR05pb01CN0FhRmVtdGQtRnVERkdZUmY5MmhXRHF3X0laR1o0ZDdJcUtGYnprdVlkaFJkcUx0bWdLcDlIblVn?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing ABIVAX Soci\u00e9t\u00e9 Anonyme (ENXTPA:ABVX) Valuation After Recent Share Price Softness And Conflicting Metrics", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPcF9UUjJDZHVTaHo3ZHRaaUFnWkVrdlk3RmhCVmVFTDZ3d3l1a2FIdjgzYTlTUzh4MjA3aWMtWWM2cTJsY28xTlF3em1NSHZ4Z3liNWZYVktWdGUyMVlLQ3lPd3JiVHVBaVRMYlAxNjJRR3c0YnpmOXIzdEZFM282U3ktRWI3T2RZc0Vwam5GWTAwVjB3RGs3VFp5blM?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX (ABVX) Appoints Michael Nesrallah as Chief Commercial Officer", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPaE5ybTFpYkl2V3hUTkJGRmh6Q0xqaTZPbzN3TTFlT3hjd3hudWF0TGI2aEdCemtnSjNndVduRFAyNmdhN2ZLWnNXeG02NkVBRDlraElPbDU5VlVLZENOYno2NnFOUEprVWVxdEl3SzB2WE1tam5BOVhNM2Z0YlRSdm9GVXZKVXBHODFCVGJxVWVzOVR1TVJjeUhHN2RPd3dTU3B0Q2lR?oc=5", "source_name": "Market source", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2 Reasons Abivax Stock Could 10X by 2036", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQc0g4S0Rqdk5DSExGdWd6NXplbjQyM2wwZWhRaHd4MVVKTEw1SmNfR1R6NGNRWURncW9GYVNwdjl4Uk1EV2xEVkE5d3pYWW9hYUpTbENPelFRQV9uYTdIVmpXaGNyTW9VaHFXUld0LUZKeDR4ZzdqTl9OWVZlT0xCUlZNeGx6OFpLSjJCMTlUZlFOdUljUDRwMHNPOVNKN1ZReTZFczZwV2loQjNHVHU4ZkgtRDBpbXNMSHc?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX Societe Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOZFN1M3ZlRlhrcENZTUJUdzRGc1g0ZHlFSVBvRERrOVNFT1JDeGV3NG93bEJBT3RkRTB4UjZoUlJCSXE3MFZEbHJKdERaemtwYThSNHp6b0FwazlyWV85OHFtS2JiNWtHVnQxWV9zZ29mZ1MtN3dWMGU5dUhPZElVek1iQTNkb09hZHF4eWx6ekFBM3lRV0c1ZmdHaGJwVWppYjd2MmpNVVRjUml5LU55UWZ1cXk2VUc2cEVFaGVia1BnV1NMTE9Yb0N1WFRZcFh3RFN1cXczZmI?oc=5", "source_name": "Finviz", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABIVAX Soci\u00e9t\u00e9 Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE0teHlFaEFzYmRPY01yTzJ1Um9DeVJjOTFnMktrejZiWGZkS3FfZ2EySW44QW01TjAxOEx6X0Ria3ZYNElXWW14Wm5vNW1pOFYyV3VkUk5vYmJDUUlKSGZsSHZkdnVhM1c3OWk1ZllQNHEzaXJYOV96aEIzWGg?oc=5", "source_name": "Market source", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Abivax Stock Was on Fire Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQd1g2SVRJOVA0Ny1mSWNNQVZjcEpxNHo5NTRXaTdnZGRkN2ZnSWtBcXE2Ym9QeXhxWVgydDhQeEZ2a1p5eXk0UUVYWW1kLTR2SUQ3MVhtV280enJQNFZtS290ZEpWSU1RS0Q1VXJuVktQbW9uWFhYX1Z3NU5Nb1JST0s3Zw?oc=5", "source_name": "The Motley Fool", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOVTdyUW5zT0llemlMZEQ1WFJDN2hQZHZlVWl0NlYyUnYzcWtvZW41WlZkcTNTLTRQSnF6bEhxSmd5M2ZROXZqNnMyVkJJNkV5WFhfSWdhUkpQRlhwYldxbUdqclJFSU9RRnhubFM1STBkLVZLLU84T2l5UGFrdUpBN0lHejlQR1EyNWotel81NXd6amUwZWkxMWFkZEw3UVp4MTlVNTBJUGVhalZwV1I3ZHNn?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-07-19T07:00:00+00:00", "published_display": "19 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 23, "sentiment_summary": {"positive": 6, "negative": 1, "neutral": 16, "score": 54, "total": 23, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 90, "events": [{"event": "general", "label": "Market update", "weight": 12.05, "count": 20}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 122.9, "latest_week": "2026-07-10", "one_week_move": -9.0, "four_week_move": 44.5, "twelve_week_move": 17.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.322456, "market_dynamics_buy_signal": false, "relative_strength": 30.904214, "fair_value_gap": 229.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.041, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-9.0% over one week, +44.5% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "MarketBeat", "count": 3}, {"label": "Seeking Alpha", "count": 3}, {"label": "Stock Traders Daily", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "CNBC", "count": 1}, {"label": "Stocktwits", "count": 1}, {"label": "The Globe and Mail", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 23}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Analyst action", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "90/100 classification confidence."}, {"label": "Company focus", "value": "23", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-9.0% over one week, +44.5% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Brummer Multi Strategy AB Boosts Position in Abivax SA Sponsored ADR $ABVX"}], "updated_at": "2026-07-17T11:08:05.091235+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}